COPING With COVID-19( CWC-19)
Sponsor
Duke University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04343690
Collaborator
(none)
0
1
1
1.1
0
Study Details
Study Description
Brief Summary
The purpose of this study is 1) to understand effects of COVID-19 crisis on wellness of pulmonary and critical care faculty and trainees who are at frontline fighting this pandemic 2) Assess the effectiveness of series of weekly web based crisis management coaching from world renowned experts in coaching and 3) identify future areas of opportunities in physician wellness
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Effectiveness of Crisis Management Coaching on Faculty and Trainee Wellness During COVID-19 Crisis
Actual Study Start Date
:
Mar 27, 2020
Actual Primary Completion Date
:
May 1, 2020
Actual Study Completion Date
:
May 1, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Health Care Workers Faculty, staff, and trainees dealing with COVID-19 pandemic |
Behavioral: Crisis management coaching
Crisis management coaching will be offered to faculty, staff, and trainees dealing with COVID-19 pandemic
|
Outcome Measures
Primary Outcome Measures
- Change in stress level as measured by survey [Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)]
Secondary Outcome Measures
- Change wellness as measured by survey [Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks)]
Survey is 14-items asking about wellness on a scale from "Strongly Agree" to "Not at all"
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Any faculty, staff, or trainee from Duke pulmonary and critical care that consents to being in the study
Exclusion Criteria:
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Duke University | Durham | North Carolina | United States | 27710 |
Sponsors and Collaborators
- Duke University
Investigators
- Principal Investigator: Patty Lee, MD, Duke University
- Principal Investigator: Sangeeta Joshi, MD, Duke University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT04343690
Other Study ID Numbers:
- Pro00105319
First Posted:
Apr 13, 2020
Last Update Posted:
Sep 23, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: